FH and hereditary leiomyomatosis and renal cell cancer: Diagnosis of HLRCC was confirmed on initial genetic testing in 25/29 in whom a heterozygous pathogenic (22/29) or likely pathogenic (3/29) FH gene variant was detected (Table 4).